TXMD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - TherapeuticsMD Inc

Watchlist Manager

Watchlist

Price: 2.18 USD 0.93% Market Closed

Market Cap: $25.2m

	TherapeuticsMD Inc NASDAQ:TXMD	US
	STRABAG SE OTC:STBBF	AT
Z	Zhejiang Expressway Co Ltd F:ZHJ	CN
B	Bidvest Group Ltd XMUN:NQL1	ZA
R	Roper Technologies Inc F:ROP	US
P	PLDT Inc F:PLO	PH
N	Nippon Steel Corp F:NPSA	JP

Profitability Summary

TherapeuticsMD Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

68%

Negative Operating Margin

-118%

Negative 3Y Average Operating Margin

-4%

Declining Operating Margin

2.006% > -118%

Negative Net Margin

-7%

Strong 3Y Average Net Margin

83%

Declining Net Margin

1.810% > -7%

Exceptional Free Cash Flow Margin

95%

Negative 3Y Average Free Cash Flow Margin

-1.087%

Free Cash Flow Margin is Increasing

-5.436% > 95%

Negative ROE

-1%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-8%

Declining ROIC

66% > -14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.